A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis
Clinical trial NCT04693195 · COMPLETED
Trial details
- NCT number
- NCT04693195
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-09
- Primary completion
- 2021-10-04
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.